Cover Image

Bradykinin content in the blood of patients with COVID-19 and diabetes mellitus

Saved in:

Bibliographic Details
Date:	2024
Main Authors:	M. D. Tronko, V. V. Pushkarev, O. I. Kovzun, L. K. Sokolova, N. I. Levchuk, V. M. Pushkarev
Format:	Article
Language:	English
Published:	2024
Series:	Reports of the National Academy of Sciences of Ukraine
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0001493737
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2021)

Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2022)

Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021)

Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021)

Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021)

NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment
by: L. K. Sokolova, et al.
Published: (2018)

Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
by: Tronko, M.D., et al.
Published: (2021)

NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment
by: Sokolova, L.K., et al.
Published: (2018)

Characteristics of Endothelial dysfunction in patients with Diabetes mellitus
by: A. S. Kuznetsova, et al.
Published: (2018)

Effect of combined treatment with insulin and metformin on 5′AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018)

Activation of the PI3K/Akt/mTOR/p70S6K1 signaling cascade in peripheral blood mononuclear cells in patients with type 2 diabetes
by: T. S. Vatseba, et al.
Published: (2020)

Cerebrovascular insufficiency and diabetic encephalopathy in patients with type 2 diabetes mellitus
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)

Cerebrovascular insufficiency and diabetic encephalopathy in patients with type 2 diabetes mellitus
by: Tovazhnyanska, E.L., et al.
Published: (2014)

Endothelial dysfunction and cerebrovascular pathology in patients with diabetes mellitus
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)

The blood leptin content and the activity of the zonal system response in patients with diabetes mellitus type 2 with different body weight and disease duration
by: B. M. Mankovskyi, et al.
Published: (2014)

Effect of combined trea tment with insulin and metformin on 5&#039;AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018)

Activation of protein kinase p70S6K1 in peripheral blood mononuclear cells of patients with cancer and diabetes
by: T. S. Vatseba, et al.
Published: (2019)

Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018)

Phosphorylation of PRAS40 in leukocytes of patients with cancer and diabetes
by: T. S. Vatseba, et al.
Published: (2019)

The peculiarities of management of the patients with arterial hypertension in combination with diabetes mellitus
by: A. N. Korzh
Published: (2012)

State of lipid peroxidation in patients with diabetes mellitus and erectile dysfunction
by: R. S. Rzaev
Published: (2021)

Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018)

Specificity of perception and emotions in patients with schizophrenia with diabetes mellitus type 2
by: Ye. V. Opria
Published: (2018)

Nanomaterials in the diagnostics and therapy of diabetes mellitus
by: M. V. Tolkachov, et al.
Published: (2015)

Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease
by: V. V. Pushkarov, et al.
Published: (2021)

Alternative treatment method of diabetes mellitus patients with vast and lastingly nonhealing wounds
by: N. N. Militsa, et al.
Published: (2008)

MARK activation in human blood mononuclear cells in types 1 and 2 diabetes
by: V. V. Pushkarov, et al.
Published: (2020)

Modeling of diabetes mellitus-related depression
by: H. Li, et al.
Published: (2014)

Method of diagnosis nonalcoholic fatty liver in patients with type 2 diabetes mellitus
by: K. Kvit, et al.
Published: (2017)

The role of cytokine in differential diagnosis and treatment optimization at community acquired pneumonia in patients with diabetes mellitus
by: O. S. Makharynska, et al.
Published: (2015)

Mycosis-induced nail ingrowth in patients with diabetes mellitus and metabolic syndrome: approaches to the problem
by: A. Verhun, et al.
Published: (2016)

Cerebrovascular disorders in patients with COVID-19
by: Yu. V. Shmatko, et al.
Published: (2021)

Optimization of treatment of patients with acute cerebrovascular accident and type 2 diabetes mellitus in the stage of decompensation
by: Yu. I. Rzhevska, et al.
Published: (2020)

Rrofile of proinflammatory cytokines in type 1 diabetes mellitus
by: Yu. H. Kyiak, et al.
Published: (2012)

Immunoglobulin isotypes and blood monocyte subpopulations in COVID-19 female patients with different disease severity
by: K. Rebenko, et al.
Published: (2022)

Cryopreserved cord blood preparations in combined surgical treatment of purulent complications of type II Diabetes mellitus
by: Ya. O. Popovych
Published: (2014)

Levels of serum antibodies to enterobacterial lipopolysaccharides and their relationship with concentration of C-reactive protein in diabetes mellitus patients
by: A. I. Gordienko
Published: (2015)

The use of phosphodiesterase type 5 inhibitors in patients with type 2 diabetes mellitus and erectile dysfunction
by: Ye. Luchytskyi
Published: (2018)

Effects of trimethylamine-n-oxide inhibitor in combination with anticholinesterase in patients with type 2 diabetes mellitus
by: O. Kikhtiak, et al.
Published: (2018)

Absolute insulin insufficiency in different variants of diabetes mellitus
by: T. M. Tikhonova, et al.
Published: (2018)